Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 3, 2003

View Archived Issues

Novel agents for gastroesophageal reflux disease identified at AstraZeneca

Evidence of antitumor activity found for Xyotax in recurrent ovarian cancer

Elan and Pharmacia present novel beta-secretase inhibitors for AD and other disorders

Orally active analgesics with minimal stimulant effects discovered at Dainippon

Grelan researchers prepare and test new naphthyridine-based PDE4 inhibitors

Novel PPAR agonists identified by Eisai scientists

Fuji Yakuhin identifies new series of antitumor agents

Selective, small-molecule inhibitor of AKT kinase activity induces apoptosis in cancer cells

Texas Biotechnology to reacquire full sitaxsentan rights

Toray and Fujisawa to codevelop TRK-820 in Europe

New Bcl-2/Bcl-XL inhibitor may facilitate chemotherapy in resistant ovarian cancer

GenoMed evaluates intravenous drug regimen for acute kidney failure

Sunesis awarded SBIR grant for novel kinase inhibitor drug discovery

Recent accomplishments at Icos

Docetaxel followed by NS-398 results in additive apoptotic effect in ovarian cancer cells

ATN-161 enters the clinic

Corixa and GSK form cancer vaccine collaboration

Phase IIb trial of eculizumab in rheumatoid arthritis completes enrollment

Catholic University of Louvain to terminate agreement with BioTransplant

French researchers identify potent and selective 5-HT4 antagonist/partial agonist

BioSante signs malaria vaccine CRADA with U.S. Navy

Ivax to develop immunotoxin to treat HIV

New Japanese pharmaceutical company begins operations

FDA accepts memantine filing

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...